Noscendo GmbH
Noscendo provides the most reliable results on sepsis-causing pathogens to intensive care specialists. Noscendo enables clinicians to save lifes of critically ill patients with appropriate targeted treatment by prompt diagnostic results.
Errungenschaften
Team
Prototyp
Nutzer
Partner
Umsätze
Investoren
Unser Angebot
We perform Next-Generation Sequencing on blood samples of septic patients and apply our newly-developed SIQ score to provide a most reliable, fast pathogen identification to the attending intensive care specialist, offering a competitive, new technology to standard blood culture.
Team
Hauptsitz
Weitere Startups
Diese Gründungsprojekte könnten auch interessant für Dich sein!